Kiremit-Korkut Neşe, Korkut Cağatay, Bilge Hatice
Institute for Experimental Medical Research, University of Istanbul, Istanbul, Turkey.
Department of General Surgery, Istanbul Faculty of Medicine, University of Istanbul, Istanbul, Turkey.
Curr Ther Res Clin Exp. 2004 Sep;65(5):433-42. doi: 10.1016/j.curtheres.2004.10.001.
Radiation rectitis is a major problem associated with high-doseirradiation used for pelvic malignancies.
The aim of this study was to investigate the possible protectiveeffect of mesalamine against irradiation-induced oxidative tissue damage in an experimental model.
THREE GROUPS OF FEMALE SPRAGUE DAWLEY RATS WERE ASSIGNED TO RECEIVE TREATMENT AS FOLLOWS: mesalamine enema (60 mg/mL) BID + irradiation (IR) was given to the mesalamine + IR group, and isotonic saline enema BID + irradiation to the control group. Treatments were given from the day before irradiation until euthanization (72 hours after the irradiation). Sham control rats received isotonic saline enema BID but no irradiation. On the third day of treatment, all animals were euthanized, and reduced glutathione (GSH) level, malondialdehyde (MDA) level, and myeloperoxidase (MPO) activity were measured in the rectal, intestinal, and hepatic tissue of the rats.
The sham group comprised 7 rats; the control and mesalamine + IRgroups, 16 rats each. The median GSH levels of rectal and intestinal specimens were lower in the control group compared with the sham group. The rectal and intestinal MDA levels were higher in the control group compared with the sham group. The rectal and intestinal MPO activities were higher in the control group compared with the sham group. All of these differences were statistically significant (P < 0.001) and indicated oxidative stress. With the topical application of mesalamine, the GSH and MDA levels and MPO activities were similar to those of the sham group.
The pelvic irradiation of rats caused oxidative rectal, intestinal,and hepatic tissue damage, which was ameliorated with the use of mesalamine.
放射性直肠炎是盆腔恶性肿瘤高剂量放疗相关的一个主要问题。
本研究旨在探讨美沙拉嗪在实验模型中对辐射诱导的组织氧化损伤的可能保护作用。
将三组雌性斯普拉格-道利大鼠按以下方式进行处理:美沙拉嗪灌肠剂(60mg/mL)每日两次+放疗给予美沙拉嗪+放疗组,等渗盐水灌肠剂每日两次+放疗给予对照组。从放疗前一天开始给药直至安乐死(放疗后72小时)。假手术对照大鼠接受等渗盐水灌肠剂每日两次但不进行放疗。在治疗的第三天,所有动物均被安乐死,并测定大鼠直肠、肠道和肝脏组织中的还原型谷胱甘肽(GSH)水平、丙二醛(MDA)水平和髓过氧化物酶(MPO)活性。
假手术组有7只大鼠;对照组和美沙拉嗪+放疗组各有16只大鼠。与假手术组相比,对照组直肠和肠道标本的GSH水平中位数较低。与假手术组相比,对照组直肠和肠道的MDA水平较高。与假手术组相比,对照组直肠和肠道的MPO活性较高。所有这些差异均具有统计学意义(P<0.001),表明存在氧化应激。局部应用美沙拉嗪后,GSH和MDA水平以及MPO活性与假手术组相似。
大鼠盆腔放疗导致直肠、肠道和肝脏组织氧化损伤,使用美沙拉嗪可改善这种损伤。